Drug Manufacturers - Specialty & Generic · Healthcare
CFO, Chief Accounting Officer
2026-06-30–present
Chief Accounting Officer
Trulieve Cannabis Corp. (TRLV)Equibles does not estimate personal net worth.
Get an email with a short summary when Trulieve Cannabis Corp. publishes a filing, an earnings call transcript or a press release.
Get TRLV alertsJan Reese is recorded as Chief Accounting Officer at Trulieve Cannabis Corp. (TRLV) since June 30, 2026 and CFO at Trulieve Cannabis Corp. (TRLV). The newest filing on record that lists Jan Reese as CFO at Trulieve Cannabis Corp. (TRLV) is dated April 29, 2026. Trulieve Cannabis Corp. reported in an 8-K filed July 2, 2026 that Jan Reese was appointed principal accounting officer, effective June 30, 2026. Trulieve Cannabis Corp. reported in an 8-K filed August 27, 2025 that Jan Reese was appointed Chief Financial Officer, effective September 8, 2025. The proxy statement of Trulieve Cannabis Corp. reports total compensation of $192,719 for Jan Reese in fiscal 2025, including a base salary of $127,885. Disclosed compensation is on record for 3 fiscal years. Jan Reese has spoken on 1 earnings call across 1 company, most recently for Trulieve Cannabis Corp. on August 7, 2026. Trulieve Cannabis Corp. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Trulieve Cannabis Corp. includes Kim Rivers (CEO and Board Member), Ryan Blust (CFO), Timothy Mullany (CFO) and 7 others.
“the Company appointed Jan Reese, the Company’s Chief Financial Officer (principal financial officer), as the Company’s principal accounting officer, effective June 30, 2026.”
“On August 27, 2025, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Jan Reese as the Company’s Chief Financial Officer, effective September 8th.”
“As a reminder, second quarter reported results under GAAP include both the true leaf and harvest operations until the deconsolidation event on June 3rd, and only true leaf medical operations as a remainder of June.”
2026-06-30–present
Start not stated–present
Last confirmed April 29, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CFO, Chief Accounting Officer
2026-06-30–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trulieve Cannabis Corp. (TRLV) | Chief Financial Officer | $127,885 | $192,719 |
| 2024 | Trulieve Cannabis Corp. (TRLV) | Chief Financial Officer | — | — |
| 2023 | Trulieve Cannabis Corp. (TRLV) | Chief Financial Officer | — | — |